These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

155 related items for PubMed ID: 7249373

  • 21. Succinylacetone inhibits delta-aminolevulinate dehydratase and potentiates the drug and steroid induction of delta-aminolevulinate synthase in liver.
    Sassa S, Kappas A.
    Trans Assoc Am Physicians; 1982; 95():42-52. PubMed ID: 7182986
    [Abstract] [Full Text] [Related]

  • 22. Chemical analysis of succinylacetone and 4-hydroxyphenyllactate in amniotic fluid using selective ion monitoring.
    Jakobs C, Sweetman L, Nyhan WL.
    Prenat Diagn; 1984; 4(3):187-94. PubMed ID: 6463026
    [Abstract] [Full Text] [Related]

  • 23. Two missense mutations causing tyrosinemia type 1 with presence and absence of immunoreactive fumarylacetoacetase.
    Rootwelt H, Chou J, Gahl WA, Berger R, Coşkun T, Brodtkorb E, Kvittingen EA.
    Hum Genet; 1994 Jun; 93(6):615-9. PubMed ID: 8005583
    [Abstract] [Full Text] [Related]

  • 24. Deficiency of fumarylacetoacetase without hereditary tyrosinemia.
    Kvittingen EA, Børresen AL, Stokke O, van der Hagen CB, Lie SO.
    Clin Genet; 1985 Jun; 27(6):550-4. PubMed ID: 4017276
    [Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27. Enzyme defect in a case of tyrosinemia type I, acute form.
    Furukawa N, Kinugasa A, Seo T, Ishii T, Ota T, Machida Y, Inoue F, Imashuku S, Kusunoki T, Takamatsu T.
    Pediatr Res; 1984 May; 18(5):463-6. PubMed ID: 6145143
    [Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. Identification of a stop mutation in five Finnish patients suffering from hereditary tyrosinemia type I.
    St-Louis M, Leclerc B, Laine J, Salo MK, Holmberg C, Tanguay RM.
    Hum Mol Genet; 1994 Jan; 3(1):69-72. PubMed ID: 8162054
    [Abstract] [Full Text] [Related]

  • 36. The enzyme defects in hereditary tyrosinaemia type I.
    Furukawa N, Hayano T, Sato N, Inoue F, Machida Y, Kinugasa A, Imashuku S, Kusunoki T, Takamatisu T.
    J Inherit Metab Dis; 1984 Jan; 7 Suppl 2():137-8. PubMed ID: 6434869
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 8.